BlossomHill Therapeutics, Inc. (BLSM) insider trading.
In Q3 2026, insiders at BlossomHill Therapeutics, Inc. reported 21 non-derivative transactions on 22 Forms 3, 4 and 5: 7 open-market purchases worth $25.2M and 0 sales.
- Transactions
- 21
- Purchases (P)
- 7
- Sales (S)
- 0
- Net shares, P minus S
- 1,573,900
- Insiders
- 9
- Last filed
- 2026-08-12
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| OrbiMed Capital GP VIII LLC / ORBIMED ADVISORS LLC | Director | 3 | 1 | 0 |
| Gordon Carl L | Director | 3 | 1 | 0 |
| Cormorant Private Healthcare Fund VI, LP / Chen Bihua / Cormorant Private Healthcare Fund V LP / Cormorant Global Healthcare Master Fund, LP / Cormorant Private Healthcare Fund III LP / Cormorant Asset Management, LP | TenPercentOwner, Director | 3 | 1 | 0 |
| Li Yishan | Director, Officer, TenPercentOwner · Executive Chairman | 3 | 0 | 0 |
| Cui Jingrong Jean | Director, Officer, TenPercentOwner · President and CEO | 3 | 0 | 0 |
| Liptak Vincent Paul | Officer · General Counsel | 3 | 2 | 0 |
| Schmid John P. | Director | 1 | 1 | 0 |
| Keyes Jason A | Officer · Chief Financial Officer | 1 | 1 | 0 |
| Agrawal Sundeep | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-10 | OrbiMed Capital GP VIII LLC / ORBIMED ADVISORS LLC | C (A) | 1,039,996 | — | 1,039,996 | Form 4 |
| 2026-08-10 | OrbiMed Capital GP VIII LLC / ORBIMED ADVISORS LLC | C (A) | 1,049,283 | — | 2,089,279 | Form 4 |
| 2026-08-10 | OrbiMed Capital GP VIII LLC / ORBIMED ADVISORS LLC | P (A) | 625,000 | $16 | 2,714,279 | Form 4 |
| 2026-08-10 | Gordon Carl L | C (A) | 1,049,283 | — | 2,089,279 | Form 4 |
| 2026-08-10 | Gordon Carl L | C (A) | 1,039,996 | — | 1,039,996 | Form 4 |
| 2026-08-10 | Gordon Carl L | P (A) | 625,000 | $16 | 2,714,279 | Form 4 |
| 2026-08-10 | Cormorant Private Healthcare Fund VI, LP / Chen Bihua / Cormorant Private Healthcare Fund V LP / Cormorant Global Healthcare Master Fund, LP / Cormorant Private Healthcare Fund III LP / Cormorant Asset Management, LP | P (A) | 312,500 | $16 | 3,614,034 | Form 4 |
| 2026-08-10 | Cormorant Private Healthcare Fund VI, LP / Chen Bihua / Cormorant Private Healthcare Fund V LP / Cormorant Global Healthcare Master Fund, LP / Cormorant Private Healthcare Fund III LP / Cormorant Asset Management, LP | C (A) | 1,599,993 | — | 1,599,993 | Form 4 |
| 2026-08-10 | Cormorant Private Healthcare Fund VI, LP / Chen Bihua / Cormorant Private Healthcare Fund V LP / Cormorant Global Healthcare Master Fund, LP / Cormorant Private Healthcare Fund III LP / Cormorant Asset Management, LP | C (A) | 1,701,541 | — | 3,301,534 | Form 4 |
| 2026-08-10 | Schmid John P. | P (A) | 6,000 | $16 | 6,000 | Form 4 |
| 2026-08-10 | Keyes Jason A | P (A) | 700 | $16 | 700 | Form 4 |
| 2026-08-10 | Li Yishan | C (A) | 113,435 | — | 1,714,117 | Form 4 |
| 2026-08-10 | Li Yishan | C (A) | 124,779 | — | 124,779 | Form 4 |
| 2026-08-10 | Li Yishan | C (A) | 1,600,682 | — | 1,600,682 | Form 4 |
| 2026-08-10 | Cui Jingrong Jean | C (A) | 1,600,682 | — | 1,600,682 | Form 4 |
| 2026-08-10 | Cui Jingrong Jean | C (A) | 124,779 | — | 124,779 | Form 4 |
| 2026-08-10 | Cui Jingrong Jean | C (A) | 113,435 | — | 1,714,117 | Form 4 |
| 2026-08-10 | Agrawal Sundeep | C (A) | 578,524 | — | 578,524 | Form 4 |
| 2026-08-10 | Liptak Vincent Paul | P (A) | 2,200 | $16 | 111,412 | Form 4 |
| 2026-08-10 | Liptak Vincent Paul | C (A) | 22,687 | — | 22,687 | Form 4 |
| 2026-08-07 | Liptak Vincent Paul | P (A) | 2,500 | $15.8 | 109,212 | Form 4 |
Transaction codes in this quarter
Get BLSM insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1839970&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · BLSM company page · BlossomHill Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling BlossomHill Therapeutics, Inc. (BLSM)?
In Q3 2026, insiders at BlossomHill Therapeutics, Inc. reported 21 non-derivative transactions on 22 Forms 3, 4 and 5: 7 open-market purchases worth $25.2M and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these BlossomHill Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/blsm.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.